• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol . SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues

tetano

Editor, Senior Moderator
J Virol


. 2025 Apr 24:e0225024.
doi: 10.1128/jvi.02250-24. Online ahead of print. SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues

Ana Isabel de Ávila[SUP] 1 [/SUP], María Eugenia Soria[SUP] 1 2 [/SUP], Brenda Martínez-González[SUP] 2 3 [/SUP], Pilar Somovilla[SUP] 1 4 [/SUP], Pablo Mínguez[SUP] 5 6 7 [/SUP], Llanos Salar-Vidal[SUP] 2 8 [/SUP], Mario Esteban-Muñoz[SUP] 2 [/SUP], Marta Martín-García[SUP] 2 [/SUP], Sonia Zuñiga[SUP] 3 [/SUP], Isabel Sola[SUP] 3 [/SUP], Luis Enjuanes[SUP] 3 [/SUP], Ignacio Gadea[SUP] 2 8 [/SUP], Celia Perales[SUP] 2 3 [/SUP], Esteban Domingo[SUP] 1 [/SUP]



Affiliations
Abstract

Defective genomes are part of SARS-CoV-2 quasispecies. High-resolution, ultra-deep sequencing of bulk RNA from viral populations does not distinguish RNA mutations, insertions, and deletions in viable genomes from those in defective genomes. To quantify SARS-CoV-2 infectious variant progeny, virus from four individual plaques (biological clones) of a preparation of isolate USA-WA1/2020, formed on Vero E6 cell monolayers, was subjected to further biological cloning to yield 9 second-generation and 15 third-generation sub-clones. Consensus genomic sequences of the biological clones and sub-clones included an average of 2.8 variations per viable genome, relative to the consensus sequence of the parental USA-WA1/2020 virus. This value is 6.5-fold lower than the estimates for biological clones of other RNA viruses such as bacteriophage Qβ, foot-and-mouth disease virus, or hepatitis C virus in cell culture. The mutant spectrum complexity of the nsp12 (polymerase)- and spike (S)-coding region was unique in the progeny of each of 10 third-generation sub-clones; they shared 2.4% of the total of 164 different mutations and deletions scored in the 3,719 genomic residues that were screened. The presence of minority out-of-frame deletions revealed the ease of defective genome production from an individual infectious genome. Several low-frequency point mutations and deletions were clade-discordant in that they were not typical of USA-WA1/2020 but served to define the consensus sequences of future SARS-CoV-2 clades. Implications for SARS-CoV-2 adaptability and COVID-19 control of the viable genome heterogeneity and the generation of complex mutant spectra from individual genomes are discussed.IMPORTANCESequencing of biological clones is a means to identify mutations, insertions, and deletions located in viable genomes. This distinction is particularly important for viral populations, such as those of SARS-CoV-2, that contain large proportions of defective genomes. By sequencing biological clones and sub-clones, we quantified the heterogeneity of the viable complement of USA-WA1/2020 to be lower than exhibited by other RNA viruses. This difference may be due to a reduced mutation rate or to limited tolerance of the large coronavirus genome to incorporate mutations and deletions and remain functional or a combination of both influences. The presence of clade-discordant residues in the progeny of individual biological sub-clones suggests limitations in the occupation of sequence space by SARS-CoV-2. However, the complex and unique mutant spectra that are rapidly generated from individual genomes suggest an aptness to confront selective constraints.

Keywords: RNA virus; defective viral genome; deletion; diversity indices; mutant spectrum; point mutation; population complexity; quasispecies; ultra-deep sequencing; viral clade.

 
Back
Top Bottom